Translational Development Acquisition 

$10.4
63
+$0+0% Monday 20:00

Statistics

Day High
0
Day Low
0
52W High
10.9
52W Low
10.13
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18MayExpected
Q1 2024
Q1 2024
Q2 2025
Q3 2025
Q4 2025
Next
-1.3
-1.26
-1.23
-1.19
Expected EPS
N/A
Actual EPS
N/A

Financials

-2,693.15%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.13MRevenue
-57.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TDACU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Trident Acquisitions Corp. is a shell company. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company focuses on identifying a business to a particular industry or geographic region of the world. The Company is focused on seeking business combination with oil and gas or other natural resources companies in Eastern Europe. The Company is not engaged in any business operations.
Show more...
CEO
Mr. Michael M. B. Hoffman J.D.
Country
US
ISIN
KYG9008W1217

Listings

0 Comments

Share your thoughts

FAQ

What is Translational Development Acquisition stock price today?
The current price of TDACU is $10.4 USD — it has increased by +0% in the past 24 hours. Watch Translational Development Acquisition stock price performance more closely on the chart.
What is Translational Development Acquisition stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Translational Development Acquisition stocks are traded under the ticker TDACU.
What is Translational Development Acquisition revenue for the last year?
Translational Development Acquisition revenue for the last year amounts to 2.13M USD.
What is Translational Development Acquisition net income for the last year?
TDACU net income for the last year is -57.42M USD.
When did Translational Development Acquisition complete a stock split?
Translational Development Acquisition has not had any recent stock splits.
Where is Translational Development Acquisition headquartered?
Translational Development Acquisition is headquartered in New York, US.